Toronto Dominion Bank’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.91M | Buy |
34,821
+6,189
| +22% | +$340K | ﹤0.01% | 824 |
|
|
2025
Q1 | $2.02M | Buy |
28,632
+3,770
| +15% | +$266K | ﹤0.01% | 758 |
|
|
2024
Q4 | $1.63M | Buy |
24,862
+920
| +4% | +$60.5K | ﹤0.01% | 784 |
|
|
2024
Q3 | $1.68M | Buy |
23,942
+5,711
| +31% | +$401K | ﹤0.01% | 679 |
|
|
2024
Q2 | $1.5M | Sell |
18,231
-1,523
| -8% | -$125K | ﹤0.01% | 715 |
|
|
2024
Q1 | $1.73M | Sell |
19,754
-416,497
| -95% | -$36.4M | ﹤0.01% | 700 |
|
|
2023
Q4 | $42.1M | Sell |
436,251
-471,503
| -52% | -$45.5M | 0.06% | 190 |
|
|
2023
Q3 | $80.3M | Buy |
907,754
+860,782
| +1,833% | +$76.2M | 0.13% | 103 |
|
|
2023
Q2 | $4.07M | Sell |
46,972
-7,314
| -13% | -$633K | 0.01% | 655 |
|
|
2023
Q1 | $5.28M | Sell |
54,286
-2,705
| -5% | -$263K | 0.01% | 570 |
|
|
2022
Q4 | $5.9M | Buy |
56,991
+15,868
| +39% | +$1.64M | 0.01% | 538 |
|
|
2022
Q3 | $3.48M | Buy |
41,123
+57
| +0.1% | +$4.83K | 0.01% | 606 |
|
|
2022
Q2 | $3.4M | Buy |
41,066
+1,749
| +4% | +$145K | 0.01% | 638 |
|
|
2022
Q1 | $3.03M | Buy |
39,317
+3,159
| +9% | +$244K | ﹤0.01% | 690 |
|
|
2021
Q4 | $3.2M | Buy |
36,158
+10,344
| +40% | +$914K | ﹤0.01% | 714 |
|
|
2021
Q3 | $2M | Buy |
25,814
+1,274
| +5% | +$98.5K | ﹤0.01% | 751 |
|
|
2021
Q2 | $2.05M | Buy |
24,540
+4
| +0% | +$334 | ﹤0.01% | 741 |
|
|
2021
Q1 | $1.85M | Sell |
24,536
-9,612
| -28% | -$726K | ﹤0.01% | 747 |
|
|
2020
Q4 | $2.99M | Buy |
34,148
+3,450
| +11% | +$302K | 0.01% | 676 |
|
|
2020
Q3 | $2.34M | Buy |
30,698
+2,906
| +10% | +$221K | 0.01% | 680 |
|
|
2020
Q2 | $3.43M | Buy |
27,792
+1,996
| +8% | +$246K | 0.01% | 643 |
|
|
2020
Q1 | $2.18M | Sell |
25,796
-6,031
| -19% | -$509K | 0.01% | 605 |
|
|
2019
Q4 | $2.69M | Buy |
31,827
+2,668
| +9% | +$226K | ﹤0.01% | 614 |
|
|
2019
Q3 | $1.97M | Sell |
29,159
-27,381
| -48% | -$1.85M | ﹤0.01% | 647 |
|
|
2019
Q2 | $2.42M | Buy |
56,540
+24,061
| +74% | +$1.03M | 0.01% | 626 |
|
|
2019
Q1 | $2.88M | Buy |
32,479
+8,147
| +33% | +$723K | ﹤0.01% | 597 |
|
|
2018
Q4 | $2.07M | Buy |
24,332
+4,743
| +24% | +$404K | ﹤0.01% | 604 |
|
|
2018
Q3 | $1.9M | Buy |
19,589
+2,040
| +12% | +$198K | ﹤0.01% | 613 |
|
|
2018
Q2 | $1.65M | Buy |
17,549
+5,527
| +46% | +$521K | ﹤0.01% | 626 |
|
|
2018
Q1 | $974K | Buy |
12,022
+1,693
| +16% | +$137K | ﹤0.01% | 642 |
|
|
2017
Q4 | $921K | Buy |
10,329
+2,960
| +40% | +$264K | ﹤0.01% | 628 |
|
|
2017
Q3 | $686K | Buy |
7,369
+5,245
| +247% | +$488K | ﹤0.01% | 642 |
|
|
2017
Q2 | $193K | Buy |
2,124
+243
| +13% | +$22.1K | ﹤0.01% | 719 |
|
|
2017
Q1 | $165K | Buy |
1,881
+401
| +27% | +$35.2K | ﹤0.01% | 725 |
|
|
2016
Q4 | $123K | Buy |
1,480
+79
| +6% | +$6.57K | ﹤0.01% | 733 |
|
|
2016
Q3 | $130K | Buy |
1,401
+513
| +58% | +$47.6K | ﹤0.01% | 721 |
|
|
2016
Q2 | $69K | Buy |
888
+3
| +0.3% | +$233 | ﹤0.01% | 621 |
|
|
2016
Q1 | $73K | Buy |
+885
| New | +$73K | ﹤0.01% | 643 |
|